Email Updates

You are here

HIV Vaccine: Better to Start Together?

Include in
Published Research

Persistence of effective immune responses remains an important concern for AIDS vaccines. The rapid onset of antibody development suggests the possibility to reassess vaccination schedules, perhaps prolonging time between boosts. The fact that improved humoral immunity was seen with both the NYVAC vector and the DNA vector shows that this co-delivery strategy can be implemented using different vaccine modalities and suggests applications beyond HIV vaccines.

October 7, 2019
Lancet HIV